Stay updated with breaking news from Nasdaq Ptct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Morgan Stanley upgraded shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) from an underweight rating to an equal weight rating in a report released on Monday, Benzinga reports. Morgan Stanley currently has $30.00 price objective on the biopharmaceutical company’s stock, up from their prior price objective of $28.00. Several other research analysts also recently commented […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shares shot up 6.1% during trading on Monday . The company traded as high as $30.49 and last traded at $30.30. 137,088 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 960,482 shares. The stock had previously closed at $28.57. […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s stock price traded up 6.1% during trading on Monday . The stock traded as high as $30.49 and last traded at $30.30. 137,088 shares were traded during mid-day trading, a decline of 86% from the average session volume of 960,482 shares. The stock had previously closed at […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% on Monday . The company traded as high as $30.49 and last traded at $30.30. 137,088 shares traded hands during trading, a decline of 86% from the average session volume of 960,482 shares. The stock had previously closed at $28.57. Wall Street Analyst Weigh […]
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.20) EPS for the quarter, beating analysts’ consensus estimates of ($1.21) by $0.01, reports. The company had revenue of $210.12 million during the quarter, compared to analyst estimates of $160.27 million. PTC Therapeutics updated its FY 2024 […]